In a Facebook Live interview from Cape Town, South Africa earlier this week, we heard from NIH’s Dr. Carl Dieffenbach about the exciting launch of HVTN 702, a new HIV vaccine clinical trial supported by NIH. The first HIV vaccine efficacy study to launch
Read More...
Read the complete post at https://blog.aids.gov/2016/12/nihs-dr-dieffenbach-discusses-launch-of-hiv-vaccine-clinical-trial-in-south-africa.html
Posted
Dec 02 2016, 08:01 AM
by
blog.aids.gov — HIV Policy & Programs. Research. New Media.